Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer

Cancer Letters

Volumn 357, Issue 2, 2015, Pages 488-497

  Kim, Sinae ^a   Rhee, Je keun ^b   Yoo, Hyun Ju ^b   Lee, Hee Jin ^b   Lee, Eun Ji ^a   Lee, Jong Won ^b   Yu, Jong Han ^b   Son, Byung Ho ^b   Gong, Gyungyup ^b   Kim, Sung Bae ^b   Singh, Shree Ram ^c   Ahn, Sei Hyun ^b   Chang, Suhwan ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; MiR 155; SLC19A2; SLC25A19; Thiamine; TPK1

Indexed keywords

MICRORNA 155; THIAMINE; CARRIER PROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN; SLC19A2 PROTEIN, HUMAN; SLC25A19 PROTEIN, HUMAN; THIAMINE PYROPHOSPHOKINASE;

ARTICLE; BIOINFORMATICS; BREAST CANCER CELL LINE; CANCER CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; MDA MB 436 CELL LINE; METABOLOMICS; PROTEIN EXPRESSION; RNA ANALYSIS; SLC19A2 GENE; SLC19A3 GENE; SLC25A19 GENE; THIAMINE METABOLISM; TPK1 GENE; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; VITAMIN METABOLISM; BIOLOGY; BREAST TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HOMEOSTASIS; LIQUID CHROMATOGRAPHY; METABOLISM; PATHOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HELA CELLS; HOMEOSTASIS; HUMANS; MCF-7 CELLS; MEMBRANE TRANSPORT PROTEINS; METABOLOMICS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; THIAMIN PYROPHOSPHOKINASE; THIAMINE; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84920831215     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.058     Document Type: Article

References (46)

1. Sand M. The pathway of miRNA maturation. Methods Mol. Biol 2014, 1095:3-10.
2. Akbari Moqadam F., Pieters R., den Boer M.L. The hunting of targets: challenge in miRNA research. Leukemia 2013, 27:16-23.
3. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318(5858):1931-1934.
4. Flynt A.S., Lai E.C. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat. Rev. Genet 2008, 9(11):831-842.
5. Palanichamy J.K., Rao D.S. miRNA dysregulation in cancer: towards a mechanistic understanding. Front. Genet 2014, 5:54.
6. Seol H.S., Akiyama Y., Shimada S., Lee H.J., Kim T.I., Chun S.M., et al. Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes. Cancer Lett 2014, 353(2):232-241.
7. Gao X., Jin W. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Cancer Lett 2014, 353(1):25-31.
8. Su Y., Li X., Ji W., Sun B., Xu C., Li Z., et al. Small molecule with big role: microRNAs in cancer metastatic microenvironments. Cancer Lett 2014, 344(2):147-156.
9. Shen J., Stass S.A., Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 2013, 329(2):125-136.
10. Ross S.A., Davis C.D. The emerging role of microRNAs and nutrition in modulating health and disease. Annu. Rev. Nutr 2014, 34:305-336.
11. Chen S., Xue Y., Wu X., Le C., Bhutkar A., Bell E.L., et al. Global microRNA depletion suppresses tumor angiogenesis. Genes Dev 2014, 28(10):1054-1067.
12. Singh S.R., Rameshwar P. MicroRNA in Development and in the Progression of Cancer 2014, Springer, New York.
13. Wang J., Wu J. Role of miR-155 in breast cancer. Front. Biosci 2012, 17:2350-2355.
14. Gasparini P., Lovat F., Fassan M., Casadei L., Cascione L., Jacob N.K., et al. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc. Natl. Acad. Sci. U.S.A. 2014, 111(12):4536-4541.
15. Chen Z., Ma T., Huang C., Hu T., Li J. The pivotal role of microRNA-155 in the control of cancer. J. Cell. Physiol 2014, 229(5):545-550.
16. Tam W., Ben-Yehuda D., Hayward W.S. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol 1997, 17:1490-1502.
17. Dacic S., Kelly L., Shuai Y., Nikiforova M.N. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod. Pathol 2010, 23(12):1577-1582.
18. Jay C., Nemunaitis J., Chen P., Fulgham P., Tong A.W. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol 2007, 26:293-300.
19. Day E.O., Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010, 12:201.
20. Chang S., Wang R.H., Akagi K., Kim K.A., Martin B.K., Cavallone L., et al. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat. Med 2011, 17:1275-1282.
21. Mattiske S., Suetani R.J., Neilsen P.M., Callen D.F. The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol. Biomarkers Prev 2012, 21:1236-1243.
22. Lössner C., Meier J., Warnken U., Rogers M.A., Lichter P., Pscherer A., et al. Quantitative proteomics identify novel miR-155 target proteins. PLoS ONE 2011, 6(7):e22146.
23. Kong W., He L., Richards E.J., Challa S., Xu C.X., Permuth-Wey J., et al. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 2014, 33(6):679-689.
24. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 2009, 1792:497-505.
25. Boros L.G., Brandes J.L., Lee W.N., Cascante M., Puigjaner J., Revesz E., et al. Thiamine supplementation to cancer patients: a double edged sword. Anticancer Res 1998, 18:595-602.
26. Gorbach Z.V., Maglysh S.S., Nefedov L.I., Ostrovskii I.u.M. [Characteristics of intracellular metabolism of carbohydrates and amino acids in animals with thiamine deficiency]. Biokhimiia 1987, 52:42-52.
27. Inui H., Nakano Y. [Vitamin B1]. Nihon Rinsho 1999, 57:2187-2192.
28. Singleton C.K., Martin P.R. Molecular mechanisms of thiamine utilization. Curr. Mol. Med 2001, 1:197-207.
29. Rajgopal A., Edmondnson A., Goldman I.D., Zhao R. SLC19A3 encodes a second thiamine transporter ThTr2. Biochim. Biophys. Acta 2001, 1537:175-178.
30. Deus B., Blum H.E., Holzer H. Radiometric assay procedure for thiamine pyrophosphokinase activity. Anal. Biochem 1969, 27:492-501.
31. Voskoboev A.I., Chernikevich I.P., Ostrovsky Y.M. [Isolation and basic properties of thiamine pyrophosphokinase from brewing yeast]. Prikl. Biokhim. Mikrobiol 1975, 11:230-236.
32. Lindhurst M.J., Fiermonte G., Song S., Struys E., De Leonardis F., Schwartzberg P.L., et al. Knockout of Slc25a19 causes mitochondrial thiamine pyrophosphate depletion, embryonic lethality, CNS malformations, and anemia. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15927-15932.
33. Liu X., Lam E.K., Wang X., Zhang J., Cheng Y.Y., Lam Y.W., et al. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer. Tumour Biol 2009, 30:242-248.
34. Ng E.K., Leung C.P., Shin V.Y., Wong C.L., Ma E.S., Jin H.C., et al. Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients. PLoS ONE 2011, 6:e22233.
35. Liu S., Huang H., Lu X., Golinski M., Comesse S., Watt D., et al. Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol. Cancer Res 2003, 1:665-673.
36. Sweet R., Paul A., Zastre J. Hypoxia induced upregulation and function of the thiamine transporter, SLC19A3 in a breast cancer cell line. Cancer Biol. Ther 2010, 10:1101-1111.
37. Zastre J.A., Hanberry B.S., Sweet R.L., McGinnis A.C., Venuti K.R., Bartlett M.G., et al. Up-regulation of vitamin B1 homeostasis genes in breast cancer. J. Nutr. Biochem 2013, 24:1616-1624.
38. Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6:813-823.
39. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
40. Chang S., Biswas K., Martin B.K., Stauffer S., Sharan S.K. Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. J. Clin. Invest 2009, 119:3160-3171.
41. Jain M., Nilsson R., Sharma S., Madhusudhan N., Kitami T., Souza A.L., et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012, 336:1040-1044.
42. Daily A., Liu S., Bhatnagar S., Karabakhtsian R.G., Moscow J.A. Low-thiamine diet increases mammary tumor latency in FVB/N-Tg(MMTVneu) mice. Int. J. Vitam. Nutr. Res 2012, 82:298-302.
43. Liu S., Monks N.R., Hanes J.W., Begley T.P., Yu H., Moscow J.A. Sensitivity of breast cancer cell lines to recombinant thiaminase I. Cancer Chemother. Pharmacol 2010, 66:171-179.
44. Patterson A.D., Maurhofer O., Beyoglu D., Lanz C., Krausz K.W., Pabst T., et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 2011, 71:6590-6600.
45. Nabokina S.M., Subramanian V.S., Valle J.E., Said H.M. Adaptive regulation of human intestinal thiamine uptake by extracellular substrate level: a role for THTR-2 transcriptional regulation. Am. J. Physiol. Gastrointest. Liver Physiol 2013, 305:G593-G599.
46. Jiang S., Zhang L.F., Zhang H.W., Hu S., Lu M.H., Liang S., et al. A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J. 2012, 31:1985-1998.